Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
25
MRAM Quote, Financials, Valuation and Earnings
Last price:
$5.61
Seasonality move
:
7.41%
Day range:
$5.50 - $5.65
52-week range:
$4.34 - $7.00
Dividend yield:
0%
P/E ratio:
192.67x
P/S ratio:
2.56x
P/B ratio:
2.00x
Volume:
66.9K
Avg. volume:
82.6K
1-year change:
-4.27%
Market cap:
$126M
Revenue:
$50.4M
EPS (TTM):
-$0.01
Analysts' Opinion
-
Consensus RatingEverspin Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.00, Everspin Technologies has an estimated upside of 51.52% from its current price of $5.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing 100% downside risk from its current price of $5.61.
Fair Value
-
According to the consensus of 1 analyst, Everspin Technologies has 51.52% upside to fair value with a price target of $9.00 per share.
MRAM vs. S&P 500
-
Over the past 5 trading days, Everspin Technologies has underperformed the S&P 500 by -10.46% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Everspin Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Everspin Technologies revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Everspin Technologies reported revenues of $13.1M.
Earnings Growth
-
Everspin Technologies earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Everspin Technologies reported earnings per share of -$0.05.
Enterprise value:
83.9M
EV / Invested capital:
--
Price / LTM sales:
2.56x
EV / EBIT:
117.54x
EV / Revenue:
1.71x
PEG ratio (5yr expected):
0.33x
EV / Free cash flow:
12.74x
Price / Operating cash flow:
19.12x
Enterprise value / EBITDA:
70.49x
Gross Profit (TTM):
$24.7M
Return On Assets:
-0.25%
Net Income Margin (TTM):
-0.37%
Return On Equity:
-0.31%
Return On Invested Capital:
-0.31%
Operating Margin:
-14.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $60.5M | $63.3M | $49.1M | $14.4M | $13.1M | |
| Gross Profit | $34.1M | $37M | $24.7M | $8.2M | $6.8M | |
| Operating Income | $4.9M | $4.6M | -$8.4M | -$600K | -$1.9M | |
| EBITDA | $6.3M | $8.9M | $1.2M | -$202K | -$1.1M | |
| Diluted EPS | $0.23 | $0.37 | -$0.01 | -$0.01 | -$0.05 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $31.4M | $37M | $42.2M | $56.4M | $66.8M | |
| Total Assets | $35.1M | $42.7M | $52.4M | $66.2M | $80.2M | |
| Current Liabilities | $12.8M | $8.5M | $6.3M | $5.9M | $12.6M | |
| Total Liabilities | $16.9M | $12.6M | $11.8M | $10.4M | $17.2M | |
| Total Equity | $18.2M | $30.1M | $40.6M | $55.8M | $63M | |
| Total Debt | $7.5M | $4.3M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $11.7M | $10.6M | $9.8M | -$1.3M | $1.4M | |
| Cash From Investing | -$3.6M | -$1.6M | -$3.2M | -$1.2M | -$1.4M | |
| Cash From Financing | -$3.8M | $1.5M | $771K | $353K | $12K | |
| Free Cash Flow | $7.9M | $9M | $6.6M | -$2.5M | $49K | |
MRAM
Sector
Market Cap
$126M
$79.6M
Price % of 52-Week High
80.14%
61.26%
Dividend Yield
0%
0%
Shareholder Yield
--
0.79%
1-Year Price Total Return
-4.27%
-14.63%
Beta (5-Year)
0.308
0.829
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.87
200-day SMA
Sell
Level
$5.81
Bollinger Bands (100)
Sell
Level
5.15 - 6.19
Chaikin Money Flow
Buy
Level
68.4M
20-day SMA
Sell
Level
$5.93
Relative Strength Index (RSI14)
Sell
Level
45.63
ADX Line
Sell
Level
30.08
Williams %R
Buy
Level
-85
50-day SMA
Buy
Level
$5.42
MACD (12, 26)
Buy
Level
0.07
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
124M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.6193)
Buy
CA Score
(Annual)
Level (1.2449)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.0736)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).
Stock Forecast FAQ
In the current month, MRAM has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MRAM average analyst price target in the past 3 months is $9.00.
-
Where Will Everspin Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Everspin Technologies share price will rise to $9.00 per share over the next 12 months.
-
What Do Analysts Say About Everspin Technologies?
Analysts are divided on their view about Everspin Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Everspin Technologies is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Everspin Technologies's Price Target?
The price target for Everspin Technologies over the next 1-year time period is forecast to be $9.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MRAM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Everspin Technologies is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of MRAM?
You can purchase shares of Everspin Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Everspin Technologies shares.
-
What Is The Everspin Technologies Share Price Today?
Everspin Technologies was last trading at $5.61 per share. This represents the most recent stock quote for Everspin Technologies. Yesterday, Everspin Technologies closed at $5.61 per share.
-
How To Buy Everspin Technologies Stock Online?
In order to purchase Everspin Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
